Data on the potential relationship between cannabis use and CVD remain mixed. For now, however, there is enough evidence available that heart patients should be careful. 

PAD patients treated with GLP-1 receptor agonists lived longer, stayed out of the hospital more and experienced fewer amputations than those given metformin.

The AI software, which has already received CE mark approval, provides care teams with a noninvasive way to secure FFR values from routine coronary angiography. 

Researchers are comparing the new-look Topaz TTVR system from TRiCares with the FDA-approved Evoque TTVR system from Edwards Lifesciences. 

Lisa Nee, MD, a former interventional cardiologist and public policy advisor, has officially joined a crowded mayoral race. 

Eplontersen, a once-monthly ATTR-CM medication from AstraZeneca and Ionis Pharmaceuticals, failed to meet the primary endpoint of a new placebo-controlled analysis. The companies are still reviewing the final data, which will be presented to the public in August. 

Certain lots of a popular diuretic have been recalled due to concerns about the drug's effectiveness. 

Cardiologist Michael McMullan, MD, was surprised by his own CCTA results, highlighting the substantial impact these scans can make on patient care. 

Researchers explored data from more than 117,000 women, tracking several lifestyle habits over an extended period of time.

The concept of the healthcare workplace champion may be ripe for developing and expanding in this time of protracted workforce shortages. Researchers make the case in a new study, suggesting star performers can help overstretched provider organizations build resilience against demoralization in their ranks. 

David Canes, MD, a Massachusetts-based urologist, posed the question on social media July 8, garnering over 100 responses from radiologists and other physicians.